169 related articles for article (PubMed ID: 22609113)
21. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
22. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.
Bergamo A; Sava G
Dalton Trans; 2011 Aug; 40(31):7817-23. PubMed ID: 21629963
[TBL] [Abstract][Full Text] [Related]
23. Optimizing the delivery of cancer drugs that block angiogenesis.
Cao Y; Langer R
Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
[TBL] [Abstract][Full Text] [Related]
24. Metal-based antitumour drugs in the post-genomic era: what comes next?
Sava G; Bergamo A; Dyson PJ
Dalton Trans; 2011 Sep; 40(36):9069-75. PubMed ID: 21725573
[TBL] [Abstract][Full Text] [Related]
25. Cysteine proteases as targets for metal-based drugs.
Fricker SP
Metallomics; 2010 Jun; 2(6):366-77. PubMed ID: 21072382
[TBL] [Abstract][Full Text] [Related]
26. Advances in metal-carbene complexes as potent anti-cancer agents.
Gautier A; Cisnetti F
Metallomics; 2012 Jan; 4(1):23-32. PubMed ID: 22027962
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
28. Ruthenium-based complex nanocarriers for cancer therapy.
Mangiapia G; D'Errico G; Simeone L; Irace C; Radulescu A; Di Pascale A; Colonna A; Montesarchio D; Paduano L
Biomaterials; 2012 May; 33(14):3770-82. PubMed ID: 22357152
[TBL] [Abstract][Full Text] [Related]
29. Recent researches in metal supramolecular complexes as anticancer agents.
Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
[TBL] [Abstract][Full Text] [Related]
30. Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation.
Le Garrec D; Gori S; Luo L; Lessard D; Smith DC; Yessine MA; Ranger M; Leroux JC
J Control Release; 2004 Sep; 99(1):83-101. PubMed ID: 15342183
[TBL] [Abstract][Full Text] [Related]
31. Macromolecules as taxane delivery systems.
Dosio F; Stella B; Arpicco S; Cattel L
Expert Opin Drug Deliv; 2011 Jan; 8(1):33-55. PubMed ID: 21142695
[TBL] [Abstract][Full Text] [Related]
32. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
33. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
Ho YP; Au-Yeung SC; To KK
Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle therapeutics: an emerging treatment modality for cancer.
Davis ME; Chen ZG; Shin DM
Nat Rev Drug Discov; 2008 Sep; 7(9):771-82. PubMed ID: 18758474
[TBL] [Abstract][Full Text] [Related]
35. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
36. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
37. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
Low PS; Henne WA; Doorneweerd DD
Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
[TBL] [Abstract][Full Text] [Related]
38. Application of a Novel Metallomics Tool to Probe the Fate of Metal-Based Anticancer Drugs in Blood Plasma: Potential, Challenges and Prospects.
Sarpong-Kumankomah S; Gailer J
Curr Top Med Chem; 2021; 21(1):48-58. PubMed ID: 32600232
[TBL] [Abstract][Full Text] [Related]
39. Current Strategy for Cisplatin Delivery.
Yue Z; Cao Z
Curr Cancer Drug Targets; 2016; 16(6):480-8. PubMed ID: 27018267
[TBL] [Abstract][Full Text] [Related]
40. New use of metals as nanosized radioenhancers.
Pottier A; Borghi E; Levy L
Anticancer Res; 2014 Jan; 34(1):443-53. PubMed ID: 24403500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
